← Leaderboards
Ying Xian
Ut Southwestern Medical Center
$6,460,808
Attributed
$6,460,808
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,460,808 · 3
By mechanism
R01$6,460,808 · 3
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- David Eric Gerber$9,524,578
- Yang Xie$9,444,566
- Yu-Lun Liu$2,722,512
- Ann Marie Stowe$5,202,846
- Jasmin Anita Tiro$7,604,681
Others in their field
Other Emerging Leaders on “Patient Oriented”
- Abraham Aizer Brody · New York University School Of Medicine$15,928,507
- Bradley G Hammill · Duke University$15,773,864
- Conor O'Neill · University Of California, San Francisco$10,429,562
- Kevin Navin Sheth · Brigham And Women'S Hospital$10,064,078
- James Dale Berry · Brigham And Women'S Hospital$9,637,757
- Vanessa Jacoby · Theranova, Llc$8,950,586
Research focus
Patient OrientedRecurrenceIschemic StrokeMissionPharmaceutical PreparationsPublic HealthHospitalsInnovationDatabasesLinkGuidelinesClinical TrialsAmericanPreventAmerican Heart AssociationHeterogeneityAgingClinical PracticeBurden Of IllnessComorbidityCardiovascular DiseasesEventAdoptionRegistries
Grant awards (12)
Post-stroke Cognitive Impairment and Dementia$795,304
R01 · FY2025 · AG · contact PI
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation$471,127
R01 · FY2025 · AG · contact PI
Post-stroke Cognitive Impairment and Dementia$834,094
R01 · FY2024 · AG · contact PI
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation$494,276
R01 · FY2024 · AG · contact PI
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)$302,654
R01 · FY2023 · AG · contact PI
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation$493,248
R01 · FY2022 · AG · contact PI
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)$390,202
R01 · FY2022 · AG · contact PI
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation$567,718
R01 · FY2021 · AG · contact PI
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)$509,566
R01 · FY2021 · AG · contact PI
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation$576,918
R01 · FY2020 · AG · contact PI
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)$515,169
R01 · FY2020 · AG · contact PI
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)$510,532
R01 · FY2019 · AG · contact PI